Market Size of Airway Management Tubes Industry
| Study Period | 2019 - 2029 |
| Base Year For Estimation | 2023 |
| CAGR | 5.00 % |
| Fastest Growing Market | Asia Pacific |
| Largest Market | North America |
| Market Concentration | Low |
Major Players
*Disclaimer: Major Players sorted in no particular order |
Need a report that reflects how COVID-19 has impacted this market and its growth?
Airway Management Tubes Market Analysis
The airway management tube market is expected to witness a CAGR of 5% over the forecast period.
COVID-19 impacted the growth of the pulmonary drug delivery systems market. Patients suffering from respiratory diseases such as asthma and chronic obstructive pulmonary disease (COPD) were at high risk of getting coronavirus infection. This has increased the demand for airway management devices and tubes for clearing obstructions. For instance, according to an article published in Pulmonary Medicine, in March 2022, it was observed that COPD patients have worse outcomes from the coronavirus infection. Also, due to biological factors, COPD patients are more likely to acquire viral infections and suffer from COVID-19's pathophysiological effects, such as micro thrombosis, intrapulmonary shunting, and subsequent bacterial infection. Thus, the increasing risk of developing COVID-19 infection among COPD patients has increased the demand for supraglottic and infraglottic devices, which increased the demand for airway management tubes during COVID-19. Hence, the COVID-19 pandemic had a favorable impact on the market initially. Currently, post-pandemic, the market has lost some traction. However, it is expected to have stable growth during the forecast period.
Factors such as the rise in incidence and prevalence of respiratory diseases, the increasing number of surgical procedures coupled with growing demand for emergency care, and increasing product approvals are boosting the market growth.
The prevalence and incidence of respiratory diseases such as asthma, chronic obstructive pulmonary diseases, and others among the population are increasing rapidly, which is anticipated to propel the market growth. For instance, according to an article published in ERS Journal, in August 2022, it was projected that about 645.6 million people (454.4 million men and 191.2 million women) are expected to have COPD by 2050, representing a 36% relative increase in global prevalence as compared to the previous year. Thus, the prevalence of COPD, a serious public health issue, is expected to rise, especially in emerging countries which is anticipated to increase the demand for airway management tubes. This is expected to fuel the market growth over the forecast period.
Additionally, as per an article published in PLOS One, in January 2021, about 2.8 million people in France are expected to have chronic obstructive pulmonary disease (COPD) by 2025. Thus, the expected increase in the number of people suffering from COPD is expected to increase the demand for airway management devices, thereby bolstering market growth.
Furthermore, the rising company activities in developing airway management systems that check for airway tube obstruction are also expected to increase the market growth over the forecast period. For instance, in May 2021, Medtronic launched its SonarMed airway monitoring system, which checks for endotracheal tube (ETT) obstruction in the United States. The device analyses ETT blockage and verifies the current position using acoustic technology and provides essential information necessary for making informed decisions on how to treat newborns and babies.
Therefore, owing to factors such as the rising burden of respiratory diseases, increasing surgical procedures as well as growing company activities, the studied market is expected to grow over the forecast period. However, the high cost of surgical procedures, lack of healthcare infrastructure, and awareness in low-income countries are expected to hinder the growth of the airway management tubes market over the forecast period.
